BASEC ID Project title Type of project Type of clinical trial Study phase (clinical trials only) multi- / monocentric Category Principal investigator Sponsor Investigational sites Lead EC Local EC(s) Approval date Minors Study Ended
2024-01768 A Phase II, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of Volrustomig Priming Regimens in Combination with other Anticancer Agents More ... clinical trial drugs phase 2 multicentric C Dr. med. Laetitia Mauti AstraZeneca AB Kantonsspital Winterthur, Winterthur
Universitätsspital Basel, Basel
Hôpitaux Universitaires de Genève, Genève
CHUV, Centre hospitalier universitaire vaudois, Lausanne
UniversitätsSpital Zürich, Züric More ...
Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Zürich, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD), Commission Cantonale d'éthique de l More ... 17.12.2024
2024-01767 The Swiss Integrated Care (INCA) Study:
Establishing a Cohort Study of Patients in Supported Family Care
non clinical, involving persons monocentric A Prof. Dr. Viktor von Wyl University of Zurich University of Zurich, Zurich
Kantonale Ethikkommission Zürich 10.01.2025
2024-01766 Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis: Is it still necessary to achieve a preoperative euthyroid state? – A prospective observational multicenter European study personal data/biological material multicentric Dr. Andrea Goldmann Kantonsspital Winterthur Kantonsspital Winterthur, Winterthur
Inselspital Bern, Bern
Clarunis St. Claraspital, Basel
Kantonsspital Baselland, Liestal
University of Geneva, Geneva
Kantonsspital St. Gallen, St. Gallen
Hospitale More ...
Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ, Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich, Commission cantonale d'Éthique de la Recherche s More ... 01.04.2025
2024-01765 A Phase 3, Randomized, Open-Label, Active-Controlled Study to Evaluate a Switch to an Oral Weekly Islatravir/Lenacapavir Regimen in People With HIV‑1 Who Are Virologically Suppressed on Standard of Ca More ... clinical trial drugs phase 3 multicentric C Prof. Dr. med. Matthias Cavassini Gilead Sciences, Inc. CHUV, Lausanne
Inselspital, Bern
HUG, Genève
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Kantonale Ethikkommission Bern, Commission Cantonale d'éthique de la recherche Genève (CCER) 23.12.2024
2024-01764 Utilization of Volatile Organic Compounds for Monitoring Treatment Responses, Detection of Postoperative Complications and Tumor Follow Up in Esophageal Cancer non clinical, involving persons monocentric A Dr. med. Dr. sc. nat. Marcel Schneider UniversitätsSpital Zürich Department of Visceral- and Transplant Surgery, University Hospital Zurich, Zurich
Kantonale Ethikkommission Zürich 10.01.2025
2024-01763 A Phase 3, Randomized, Double-Blind, Active-Controlled Study to Evaluate a Switch to an Oral Weekly Islatravir/Lenacapavir Regimen in People With HIV-1 Who Are Virologically Suppressed on Bictegravir/ More ... clinical trial drugs phase 3 multicentric C Prof. Dr. med. Matthias Cavassini Gilead Sciences, Inc. CHUV, Lausanne
Inselspital, Bern
USZ, Zürich
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich 23.12.2024
2024-01762 A comparative study of the Quantra® QStat System with rotational thromboelastometry (ROTEM® sigma) and standard laboratory coagulation tests in an obstetric population non clinical, involving persons monocentric A Dre Alexia Cuenoud CHUV - Anesthésiologie CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 05.05.2025
2024-01761 MK-1022-011: A Phase 1/2 Study to Evaluate the Safety and Efficacy of Patritumab Deruxtecan in Gastrointestinal Cancers clinical trial drugs phase 1/2 multicentric C Dr. med. Thibaud Kössler Merck Sharp & Dohme LLC Hôpitaux Universitaires Genève (HUG), Genève
UniversitätsSpital Zürich, Zürich
Commission Cantonale d'éthique de la recherche Genève (CCER) Kantonale Ethikkommission Zürich 07.11.2024
2024-01760 Epidemiologische Analyse von Krankheiten und Risikofaktoren anhand von Autopsien. personal data/biological material monocentric Dr. Umberto Maccio Universitätsspital Zürich Universitätsspital Zürich, Institut für Pathologie und Molekularpathologie, Zürich
Kantonale Ethikkommission Zürich 17.12.2024
2024-01758 1 year minimum follow up after AMIC plastic of focal chondral
defects of the first metatarsal head in beginning MTP I
arthritis
non clinical, involving persons monocentric A PD Dr. med. Stephan Wirth Universitätsklinik Balgrist Universitätsklinik Balgrist, Zürich
Kantonale Ethikkommission Zürich 15.11.2024
2024-01757 Eine Beobachtungsstudie zur Anwendung von aerosoliertem Capsaicin zur Sekretmobilisation bei Patient:innen auf der Intensivstation personal data/biological material monocentric PD Dr. med Philipp Bühler Kantonsspital Winterthur Kantonsspital Winterthur, Winterthur
Kantonale Ethikkommission Zürich 01.11.2024
2024-01756 In-hospital obesity measurement: discrepancy between prevalence and actual documentation personal data/biological material monocentric Dr. méd. Alend Saadi RHNe - Chirurgie Réseau Hospitalier Neuchâtelois, Neuchâtel
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 03.12.2024
2024-01755 Neural correlates of craving in alcohol use disorder. non clinical, involving persons monocentric A PD Dr. med. Marcus Herdener University of Zurich University of Zurich, Zurich
Kantonale Ethikkommission Zürich 10.12.2024
2024-01754 Investigation of physiological networks of sleep for memory consolidation in temporal lobe epilepsy with HD-EEG non clinical, involving persons monocentric A Project Leader (Prof Serge Vulliémoz, PhD) Hôpitaux Universitaires de Genève Hôpitaux Universitaires de Genève, Geneva
Commission Cantonale d'éthique de la recherche Genève (CCER) 28.01.2025
2024-01753 Survival and quality of life in patient with alcoholic steatohepatitis according to treatment non clinical, involving persons monocentric A PD Dr. med. Sena Blümel GAE USZ Klinik für Gastroenterologie und Hepatologie, Universitätsspital Zürich, Zürich
Kantonale Ethikkommission Zürich 07.03.2025
2024-01752 Descriptive epidemiology, evaluation of infection control measures, and assessment of transmission parameters of influenza virus at an acute care hospital in Switzerland: 2010-2024 personal data/biological material monocentric Prof. Stephan Harbarth Hôpitaux Universitaires de Genève Hôpitaux Universitaires de Genève, Genève
Commission Cantonale d'éthique de la recherche Genève (CCER) 09.12.2024
2024-01751 Targeting “inflammaging” by NAD boosting plus CD38 inhibitiOn as longevity nutritional strategy in fRAil oLder subjects: the CORAL study. Exploratory phase non clinical, involving persons monocentric A Prof Patrizia D'Amelio CHUV - Gériatrie CHUV University Hospital, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 11.11.2024
2024-01749 Etude rétrospective de capacité d'effort et de la qualité de vie des patients admis en réhabilitation respiratoire en Suisse personal data/biological material monocentric Pr Pierre-Olivier Bridevaux Hôpital du Valais Hôpital du Valais, Martigny
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 27.01.2025
2024-01748 L’effet vécu des médicaments antidépresseurs : exploration qualitative phénoménologique non clinical, involving persons monocentric A Dr. Michael Saraga CHUV - Psychiatrie CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 26.11.2024
2024-01747 LACPYSEP - Lactate to pyruvate ratio to assess tissue dysoxia in septic shock. non clinical, involving persons monocentric A Dr Zied Ltaief CHUV - SMIA CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 16.10.2024